Reportedly, the patent-pending orthopedic device allows for the fixation of adjacent vertebral segments with minimal tissue disruption while attaining the biomechanical advantages of a traditional full-exposure system.
By entering into the license agreement, X-spine furthers its strategy to address the continuing market trend towards smaller, cost-effective procedures in spinal surgery.
Vijay Goel, founder of Gamma Spine, said: “X-spine is the ideal partner to bring this technology to the worldwide marketplace; the company has an excellent track record of bringing innovative technology to fruition through its top-down emphasis on engineering, research, and development.”
David Kirschman, president and CEO of X-spine, said: “I am thrilled be working with Dr Goel, who is one of the renowned and published experts in spinal biomechanics, to develop this valuable technology. The patent-pending device allows for the fixation of adjacent vertebral segments with minimal tissue disruption while attaining the biomechanical advantages of a traditional full-exposure system.
“Surgeons are demanding procedure options which are less invasive for patients, less costly for payers, but maintain the ease, safety and efficacy of traditional full-exposure procedures. We feel that the Gamma technology effectively addresses that demand.”
